Back
JPMorgan Chase & Vs. Summit Therapeutics Industry Stock Comparison
Buy
56
JPM
JPMorgan Chase &
Last Price:
$287.46
Seasonality Move:
-1.09%
Buy
61
SMMT
Summit Therapeutics
Last Price:
$27.45
Seasonality Move:
9.76%
Buy
56
JPMorgan Chase & (JPM)
is a Buy
Is JPMorgan Chase & a Buy, Sell or Hold?
-
The current JPMorgan Chase & [JPM] share price is $285.82. The Score for JPM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
JPM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $28.27. The Score for SMMT is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JPM Stock Price Chart
What is JPMorgan Chase &'s stock price today?
-
The JPMorgan Chase & share price today is $285.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JPM is experiencing slight selling pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $28.27Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
JPM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 78.21 | Buy |
| Relative Strength Index (14 RSI): | 57.32 | Buy |
| Chaikin Money Flow: | -2714704 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (272.64 - 290.6) | Buy |
| Bollinger Bands (100): | (236.65 - 276.01) | Buy |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.06 | Buy |
| Relative Strength Index (14 RSI): | 66.86 | Buy |
| Chaikin Money Flow: | 4959052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.93 - 24.51) | Buy |
| Bollinger Bands (100): | (18.85 - 25.49) | Buy |
JPM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 286.75 | Sell |
| 20-day SMA: | 285.01 | Buy |
| 50-day SMA: | 271.64 | Buy |
| 200-day SMA: | 249.14 | Buy |
| 8-day EMA: | 237.1 | Buy |
| 20-day EMA: | 144.17 | Buy |
| 50-day EMA: | 69.88 | Buy |
| 200-day EMA: | 19.34 | Buy |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.91 | Buy |
| 20-day SMA: | 22.7 | Buy |
| 50-day SMA: | 22.83 | Buy |
| 200-day SMA: | 21.01 | Buy |
| 8-day EMA: | 21.32 | Buy |
| 20-day EMA: | 12.82 | Buy |
| 50-day EMA: | 6.18 | Buy |
| 200-day EMA: | 1.71 | Buy |
JPMorgan Chase & Earnings Growth & JPM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.57 per share, an increase this year of $1.04 per share, and an increase next year of $1.10 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.11 per share.
JPMorgan Chase & Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||